Managing Director Peter Sölkner leaves Vetter

Managing Director Carsten Press takes over the relevant departments

14-May-2025
© Vetter Pharma International GmbH

Managing Director Peter Sölkner

The global pharmaceutical service provider Vetter announces changes within its management team: Peter Sölkner is leaving Vetter at his own request to pursue new challenges outside the company.

"Peter Sölkner has led and developed our company very successfully over many years with clear direction and vision. Under his leadership, Vetter has developed dynamically and has grown sustainably in terms of turnover and headcount. With his dedicated and value-oriented approach, Peter Sölkner has made a significant contribution to the strong market position of our family-owned company as a global player in the pharmaceutical and biotech industry," emphasizes Senator h. c. Udo J. Vetter, Chairman of the Advisory Board of the company and member of the owner family. "On behalf of the entire Advisory Board and the Management Board, I would like to thank him warmly for his many years of service. We wish him all the best and every success for the future."

Peter Sölkner has been Managing Director since 2008 and was previously responsible for the company's key account management and global supply chain. Managing Director Carsten Press will take over the areas of Corporate Development and Global Sales, which he most recently managed.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...

Last viewed contents

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand - Albert M. Baehny will retire from Lonza Group following a transition period

Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand - Albert M. Baehny will retire from Lonza Group following a transition period

Dr. Roland Durner becomes new CEO of Bioengineering AG

Dr. Roland Durner becomes new CEO of Bioengineering AG

GDCh Award for Biocatalysis for Sebastian Gergel

GDCh Award for Biocatalysis for Sebastian Gergel

Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG - Grosse to take over as Group CEO on July 1, 2025

Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG - Grosse to take over as Group CEO on July 1, 2025

WACKER BIOSOLUTIONS under New Leadership - Susanne Leonhartsberger will leave the company at her own request at the end of 2024.

WACKER BIOSOLUTIONS under New Leadership - Susanne Leonhartsberger will leave the company at her own request at the end of 2024.

DMC Biotechnologies announces Dr. Jim Flatt as CEO - DMC seeking to transform how the world makes chemicals

DMC Biotechnologies announces Dr. Jim Flatt as CEO - DMC seeking to transform how the world makes chemicals

Merck: New CEOs for Life Science and Healthcare business sectors and New Chief People Officer - Appointment of three internal senior executives ensures strategic continuity with a new era of leadership

Merck: New CEOs for Life Science and Healthcare business sectors and New Chief People Officer - Appointment of three internal senior executives ensures strategic continuity with a new era of leadership

CureVac appoints new CEO - Dr. Franz-Werner Haas to complete tenure as CEO by March 31, 2023

CureVac appoints new CEO - Dr. Franz-Werner Haas to complete tenure as CEO by March 31, 2023

LenioBio announces new CEO - Founder will be stepping down as CEO

LenioBio announces new CEO - Founder will be stepping down as CEO

T-CURX announces senior leadership appointments - T-CURX completes formation of highly experienced clinical team to rapidly advance clinical translation of its next-generation CAR-T cell therapies

T-CURX announces senior leadership appointments - T-CURX completes formation of highly experienced clinical team to rapidly advance clinical translation of its next-generation CAR-T cell therapies

Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic

Samanta Cimitan Appointed Chief Executive Officer (CEO) at Celonic